AnaptysBio, Inc. Successfully Generates Therapeutic Antibodies in Partnership with a Leading Global Pharma

SAN DIEGO--(BUSINESS WIRE)--AnaptysBio, Inc., a privately-held therapeutic antibody company, today announced the successful completion of a therapeutic antibody generation project with a leading global pharmaceutical company. This is the second successful completion of a pharma project announced by AnaptysBio in 2011.

Back to news